First-in-man study by novel EAGLE device

On March 14th 2018, BELKIN Laser (partner BEL) achieved its important milestone: treating the first patients with the EAGLE device - Direct Selective Laser Trabeculoplasty (DSLT) treatment as part of the WP1 of the GLAUrious project.

The study on limited number of patients will pave the way to GLAUrious multinational randomized controlled study initiation at Italy (UNIGE) and UK (QUB).

39 views0 comments